As of Aug 03
| -0.12 / -4.26%|
The 2 analysts offering 12-month price forecasts for Sequenom Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.50. The median estimate represents a +75.93% increase from the last price of 2.70.
The current consensus among 5 polled investment analysts is to Hold stock in Sequenom Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.